Hemab Therapeutics Holdings, Inc. (COAG)
Hemab Therapeutics Holdings, Inc.
$46.38-0.02%Healthcare
StockGlow Score
Bullish
BearishBullish
1 year ago+36.4%
The outlook
Hemab Therapeutics Holdings, Inc. currently reads as bullish based on strong buy — 1.0 avg of 5 analysts, above its 50- & 200-day averages, 80% of the way from its 52-week low to high, avg target +8% vs current price. This is a snapshot of current market data, not a forecast.
What’s behind the score
Analyst consensusStrong Buy — 1.0 avg of 5 analysts
Price trendAbove its 50- & 200-day averages
52-week range80% of the way from its 52-week low to high
Price targetAvg target +8% vs current price
Analyst price target
~12-month · 5 analysts$50.00average target+7.8% vs now
Now $46.38
Low $46.00High $55.00
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$2.17B
52-wk high
$52.15
52-wk low
$23.00
50-day avg
$33.84
200-day avg
$32.50
Trailing P/E
—